Literature DB >> 27571439

The weeks and the cumulative doses of the first adverse events related to oral isotretinoin in acne patients: analysis of 300 patients.

Duriye Deniz Demirseren1, Fadime Kilinc1, Selma Emre1, Mesut Akyol2, Ahmet Metin1, Akin Aktas1.   

Abstract

BACKGROUND: The purpose of our study is to find out in which weeks and in which cumulative doses the side effects emerge and to study whether or not there is a significant variance between the observed period and doses of the emergent side effects of the patients taking the daily doses of below and above 0.5 mg/kg.
METHODS: Patients were started treatment with doses of 0.25-1 mg/kg isotretinoin, and a form was given to the patients to mark which probable side effects occurred in which weeks and called for weekly follow-up for the first 2 months.
RESULTS: The median of the complaints of emerged side effects such as chellitis, dry face and facial erythema, photobia and nyctalopia was in less than 4 weeks. When the doses taken below and above 0.5 mg/kg are compared, the side effects observed to have differences between both the week they occurred and the cumulative doses are xerosis, dry face, exacerbation of acnes, nervousness, and somnolence.
CONCLUSIONS: We believe that knowing which weeks the side effects are observed first, warning about the side effects that may especially occur in the first 4 weeks, and ensuring some measures are taken before the side effects are observed will increase the success of patient compatibility and management of side effects.

Entities:  

Keywords:  Acne vulgaris; adverse events; isotretinoin; side effect

Mesh:

Substances:

Year:  2016        PMID: 27571439     DOI: 10.1080/09546634.2016.1230175

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  3 in total

1.  Trypanocidal Effect of Isotretinoin through the Inhibition of Polyamine and Amino Acid Transporters in Trypanosoma cruzi.

Authors:  Chantal Reigada; Edward A Valera-Vera; Melisa Sayé; Andrea E Errasti; Carla C Avila; Mariana R Miranda; Claudio A Pereira
Journal:  PLoS Negl Trop Dis       Date:  2017-03-17

Review 2.  Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic review.

Authors:  Yuliya Lytvyn; Katherine McDonald; Asfandyar Mufti; Jennifer Beecker
Journal:  JAAD Int       Date:  2022-02-10

3.  Effect of Serum 25 Hydroxy Vitamin D Level on Isotretinoin-Induced Musculoskeletal Symptoms: A Cross-Sectional Study.

Authors:  Cevriye Mülkoğlu; Nermin Karaosmanoğlu
Journal:  Sci Rep       Date:  2020-02-10       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.